Composition
- Active ingredients
- EXENATIDE SYNTHETIC 2MG/VIAL
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA022200.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Bydureon
- Active substance
- exenatide synthetic
- Route
- Subcutaneous
- Dosage form
- For suspension, extended release
- Applicant
- Astrazeneca AB
- Status
- Discontinued
- FDA approval
- 27 Jan 2012
- Application
- NDA022200-001